Literature DB >> 7979595

Phenotypic and functional activation of alveolar macrophages, T lymphocytes and NK cells in patients with systemic sclerosis and primary Sjögren's syndrome.

B Gudbjörnsson1, R Hällgren, O Nettelbladt, R Gustafsson, A Mattsson, E af Geijerstam, T H Tötterman.   

Abstract

OBJECTIVES: Attempts to differentiate between the pathogenesis of the severe pulmonary manifestations observed in systemic sclerosis (SSc) and the mild form in primary Sjögren's syndrome (pSS) were performed by studying cell populations recovered during bronchoalveolar lavage (BAL). METHODS AND
RESULTS: Two-colour flow cytometric analysis of BAL fluid lymphocytes showed a similar degree of phenotypic activation (DR+) of CD4+ and CD8+ T lymphocyte subsets and CD16+ NK cells in patients with SSc (n = 13) and pSS (n = 11) groups and healthy controls (n = 11). Alveolar macrophages expressed the CD14 antigen at significantly increased densities in patients with SSc. Alveolar macrophage activation in SSc was also suggested by increased IL-6 concentrations in neat BAL fluid and increases in macrophage production of TNF alpha and EGF in vitro. SSc patients also had increased proportions of neutrophils and eosinophils in BAL fluid. No correlations were found between any cellular subsets or cytokine levels in BAL fluid and lung status at the time of lavage in SSc or pSS patients or the subsequent course of the pulmonary function in SSc patients.
CONCLUSION: It is concluded that the phenotypical activation of alveolar helper/inducer (DR+CD4+) and suppressor/cytotoxic (DR+CD8+) T lymphocytes and NK (DR+CD16+) cells is not a prerequisite for the development of lung fibrosis in SSc or bronchial hyper-responsiveness in pSS. Alveolar macrophage activation may contribute to the development of lung fibrosis in SSc.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7979595      PMCID: PMC1005408          DOI: 10.1136/ard.53.9.574

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  37 in total

Review 1.  Evaluation of alveolitis by studies of lung biopsies.

Authors:  P L Haslam
Journal:  Lung       Date:  1990       Impact factor: 2.584

2.  Bilateral bronchoalveolar lavage in progressive systemic sclerosis: interlobar variability, lymphocyte subpopulations, and functional correlations.

Authors:  L Frigieri; F Mormile; N Grilli; D Mancini; G Ciappi; G Pagliari; M Magarò; G Flamini
Journal:  Respiration       Date:  1991       Impact factor: 3.580

3.  Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis.

Authors:  R Gustafsson; T H Tötterman; L Klareskog; R Hällgren
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

4.  Spontaneous production of fibronectin by alveolar macrophages in patients with scleroderma.

Authors:  M B Kinsella; E A Smith; K S Miller; E C LeRoy; R M Silver
Journal:  Arthritis Rheum       Date:  1989-05

5.  The Copenhagen criteria for Sjögren's syndrome.

Authors:  R Manthorpe; P Oxholm; J U Prause; M Schiødt
Journal:  Scand J Rheumatol Suppl       Date:  1986

Review 6.  The lungs in systemic sclerosis (scleroderma): a review and new information.

Authors:  D S McCarthy; F D Baragar; S Dhingra; M Sigurdson; J B Sutherland; M Rigby; L Martin
Journal:  Semin Arthritis Rheum       Date:  1988-05       Impact factor: 5.532

7.  Serum CD14 levels in polytraumatized and severely burned patients.

Authors:  C Krüger; C Schütt; U Obertacke; T Joka; F E Müller; J Knöller; M Köller; W König; W Schönfeld
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

8.  Subclinical lung inflammation in primary Sjögren's syndrome. Relationship between bronchoalveolar lavage cellular analysis findings and characteristics of the disease.

Authors:  P Y Hatron; B Wallaert; D Gosset; A B Tonnel; B Gosselin; C Voisin; B Devulder
Journal:  Arthritis Rheum       Date:  1987-11

9.  Lymphocyte subpopulations in bronchoalveolar lavage in Sjögren's syndrome. Evidence for an expansion of cytotoxic/suppressor subset in patients with alveolar neutrophilia.

Authors:  B Wallaert; L Prin; P Y Hatron; P Ramon; A B Tonnel; C Voisin
Journal:  Chest       Date:  1987-12       Impact factor: 9.410

10.  Phenotype of peripheral blood lymphocytes in patients with progressive systemic sclerosis: activated T lymphocytes and the effect of D-penicillamine therapy.

Authors:  B Freundlich; S A Jimenez
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

View more
  8 in total

1.  Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A.

Authors:  Y Kawaguchi; M Hara; T M Wright
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis.

Authors:  M R Hussein; H I Hassan; E R M Hofny; M Elkholy; N A Fatehy; A E A Abd Elmoniem; A M Ezz El-Din; O A Afifi; H G Rashed
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

3.  Up regulated expression of fractalkine/CX3CL1 and CX3CR1 in patients with systemic sclerosis.

Authors:  M Hasegawa; S Sato; T Echigo; Y Hamaguchi; M Yasui; K Takehara
Journal:  Ann Rheum Dis       Date:  2005-01       Impact factor: 19.103

4.  CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma.

Authors:  Ayumi Yoshizaki; Yohei Iwata; Kazuhiro Komura; Fumihide Ogawa; Toshihide Hara; Eiji Muroi; Motoi Takenaka; Kazuhiro Shimizu; Minoru Hasegawa; Manabu Fujimoto; Thomas F Tedder; Shinichi Sato
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

5.  Eight-year follow-up of airway hyperresponsiveness in patients with primary Sjögren's syndrome.

Authors:  Dora Ludviksdottir; Sigridur Th Valtysdottir; Hans Hedenström; Roger Hällgren; Björn Gudbjörnsson
Journal:  Ups J Med Sci       Date:  2016-11-16       Impact factor: 2.384

Review 6.  NK Cells in the Human Lungs.

Authors:  Baptiste Hervier; Jules Russick; Isabelle Cremer; Vincent Vieillard
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

7.  Indigo Pulverata Levis (Chung-Dae, Persicaria tinctoria) Alleviates Atopic Dermatitis-like Inflammatory Responses In Vivo and In Vitro.

Authors:  Ga-Yul Min; Ji-Hye Kim; Tae-In Kim; Won-Kyung Cho; Ju-Hye Yang; Jin-Yeul Ma
Journal:  Int J Mol Sci       Date:  2022-01-05       Impact factor: 5.923

8.  Screening and identification of biomarkers for systemic sclerosis via microarray technology.

Authors:  Chen Xu; Ling-Bing Meng; Yu-Chen Duan; Yong-Jing Cheng; Chun-Mei Zhang; Xing Zhou; Ci-Bo Huang
Journal:  Int J Mol Med       Date:  2019-09-05       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.